Review of: 'A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)'
- Resource Type
- Source
- Subject
medicine.medical_specialty Endocrinology business.industry Internal medicine Meta-analysis Nonalcoholic fatty liver disease medicine Type 2 diabetes business medicine.disease Glucagon-like peptide 1 receptor - Language